Assessment of Miniature AsCas12f1 Variants for Gene Editing and Activation
Sign Up to like & getrecommendations! Published in 2025 at "Biotechnology and Bioengineering"
DOI: 10.1002/bit.28978
Abstract: Miniature CRISPR/Cas systems possess delivery advantages for gene therapy. The type V‐F Cas12f1 from Acidibacillus sulfuroxidans is exceptionally compact (422 amino acids) and has been engineered by several studies as compact genome editing tools through… read more here.
Keywords: gene editing; activation; ascas12f1; miniature ... See more keywords